Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Valerie Fonteyne

77 Results

2023

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Renée BultijnckValerie FonteyneLiv Veldeman

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

Valerie FonteyneCharles Van PraetPiet OstBen VannesteNicolaas Lumen

A1 Journal Article in EUROPEAN UROLOGY FOCUS

2022

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie FonteyneCharles Van PraetPiet OstGeert VilleirsSofie VerbekeDaan De MaeseneerElke RammantFlor VerghoteKarel Decaestecker

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Aurélie De BruyckerPiet OstValerie Fonteyne

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Liv VeldemanRenée BultijnckValerie Fonteyne

A1 Journal Article in FRONTIERS IN ONCOLOGY

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor VerghoteLeen PaelinckTom VercauterenValerie Fonteyne

A1 Journal Article in PRACTICAL RADIATION ONCOLOGY

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

Valerie FonteyneKarel DecaesteckerNicolaas LumenAurélie De BruyckerBieke LambertSofie VerbekeJo Van DorpeRenée BultijnckGeert VilleirsPiet Ost

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Physical Activity and Health-related Quality of Life from Diagnosis to One Year After Radical Cystectomy in Patients with Bladder Cancer: A Longitudinal Cohort Study

Elke RammantAnn Van HeckeJelle Van CauwenbergRenée BultijnckSofie VerhaegheBenedicte DeforcheValerie Fonteyne

U Journal Article in BLADDER CANCER

Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study

Elke RammantAnn Van HeckeJelle Van CauwenbergKarel DecaesteckerLindsay PoppeRenée BultijnckSofie VerhaegheRoos ColmanBenedicte DeforcheValerie Fonteyne

A1 Journal Article in BLADDER CANCER

Predicting patient-reported symptom clusters in prostate cancer patients : a machine learning approach

Elke RammantEmile DemanLindsay PoppeRenée BultijnckAnn Van HeckeLiv VeldemanValerie FonteyneSofie Van Hoecke

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Elke RammantAnn Van HeckeKarel DecaesteckerRoos ColmanValerie Fonteyne

U Journal Article in PSYCHO-ONCOLOGY

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Kim De RuyckLiv VeldemanValerie FonteyneRenée Bultijnck

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2021

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial

Flor VerghoteCharles Van PraetPiet OstGeert VilleirsSofie VerbekeDaan De MaeseneerKarel DecaesteckerValerie Fonteyne

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Julie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel MontenFréderic DuprezKatrien VandecasteelePiet Ost

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Liv VeldemanPiet OstValerie FonteyneYolande LievensMarc Van EijkerenChristel MontenWilfried De Neve

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Development of a pre‐ and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study) : an intervention mapping approach

Elke RammantBenedicte DeforcheAnn Van HeckeSofie VerhaegheRenée BultijnckKarel DecaesteckerValerie Fonteyne

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor VerghoteLindsay PoppeSofie VerbekePiet OstGeert VilleirsPieter De VisschereDaan De MaeseneerSylvie RotteyCharles Van PraetKarel DecaesteckerValerie Fonteyne

A1 Journal Article in BMC CANCER

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Renée BultijnckBenedicte DeforcheMaarten LievensElke RammantValerie FonteyneKarel DecaesteckerAdelheid SteyaertNicolaas LumenPiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Supportive roles of the health care team throughout the illness trajectory of bladder cancer patients undergoing radical cystectomy : a qualitative study exploring the patients’ perspectives

Elke RammantValerie FonteyneVincent Van GoethemSofie VerhaegheKarel DecaesteckerAnn Van Hecke

A1 Journal Article in SEMINARS IN ONCOLOGY NURSING

The development of a physical activity program and psychosocial framework to improve health-related quality of life in bladder cancer patients undergoing radical cystectomy

Elke RammantValerie FonteyneAnn Van HeckeSofie Verhaeghe

The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Nicolaas LumenElise De BleserSarah BuelensWesley VerlaFilip PoelaertWietse ClaeysValerie FonteyneSofie VerbekeGeert VilleirsSylvie RotteyCharles Van PraetKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenSofie VerbekeJo Van DorpeValerie FonteyneNicolaas LumenBram De LaerePiet Ost

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2020

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Liv VeldemanPiet OstValerie Fonteyne

A1 Journal Article in FRONTIERS IN ONCOLOGY

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De BleserRuben WillemsKarel DecaesteckerLieven AnnemansAurélie De BruyckerValerie FonteyneNicolaas LumenGert De MeerleerPiet OstRenée Bultijnck

A1 Journal Article in CANCERS

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Julie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel MontenFréderic DuprezKatrien VandecasteelePiet Ost

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review

Elke RammantLisa Van WilderNele PauwelsKarel DecaesteckerCharles Van PraetRenée BultijnckPiet OstSofie VerhaegheAnn Van HeckeValerie Fonteyne

A1 Journal Article in QUALITY OF LIFE RESEARCH

Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy : systematic review of the recent literature

Thomas TaillyPiet OstMarjan WaterloosKarel DecaesteckerValerie FonteyneCharles Van PraetNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

PET–CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?

Valerie FonteyneKarel DecaesteckerPieter De VisscherePiet OstGeert Villeirs

A1 Journal Article in CLINICAL AND TRANSLATIONAL IMAGING

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Valerie FonteynePiet Ost

A1 Journal Article in FUTURE ONCOLOGY

2019

Assessing the role and optimal duration of hormonal treatment in association with salvage radiation therapy after radical prostatectomy : results from a multi-institutional study

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Current insights in the management of high-risk prostate cancer : still more questions than answers

Valerie FonteynePiet Ost

Editorial material

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert DhondtElise De BleserTom ClaeysSarah BuelensNicolaas LumenJo VandesompeleValerie FonteyneKim Van der EeckenAurélie De BruyckerPiet Ost

A1 Journal Article in WORLD JOURNAL OF UROLOGY

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

Pieter De VisschereKarel DecaesteckerValerie Fonteyne

A1 Journal Article in ANNALS OF ONCOLOGY

Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer

Renée BultijnckElke RammantMartine De MuynckBenedicte DeforcheValerie FonteyneKarel DecaesteckerNicolaas LumenPiet Ost

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Sarah BuelensElise De BleserBert DhondtWesley VerlaKarel DecaesteckerPiet OstValerie FonteyneSylvie RotteyNicolaas Lumen

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Aurélie De BruyckerElise De BleserKarel DecaesteckerValerie FonteyneNicolaas LumenPieter De VisschereBieke LambertPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke RammantPiet OstBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRenée BultijnckGert De MeerleerCamille SarrazynRoos ColmanValerie Fonteyne

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Filip PoelaertValerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CHIRURGICA BELGICA

Predicting perioperative mortality after radical cystectomy : comorbidity assessment tools are only part of the puzzle

Valerie FonteyneElke RammantKarel Decaestecker

Editorial material

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Renée BultijnckGiselle PostLiv VeldemanYolande LievensMarc Van EijkerenKatrien VandecasteelePiet OstValerie FonteynePieter DeseyneWilfried De NeveFréderic DuprezMarcus MareelChristel MontenTom VercauterenLeen Paelinck

A1 Journal Article in Radiotherapy and Oncology

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah PironNick Van LaekenYves D'AsselerKlaus BacherKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas LumenEric AchtenBoudewijn BransFilip De Vos

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie Rottey

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie RotteyPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Nora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van DorpeSofie VerbekeLieve BrochezKim Van der EeckenSylvie RotteyPiet Ost

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Aurélie De BruyckerValerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Karel DecaesteckerValerie FonteynePiet OstGeert Villeirs

A1 Journal Article in BJU INTERNATIONAL

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Elke RammantValerie FonteyneKarel DecaesteckerRenée BultijnckBenedicte DeforchePiet OstSofie VerhaegheAnn Van Hecke

A1 Journal Article in CLINICAL REHABILITATION

2018

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie FonteyneCamille SarrazynGert De MeerleerElke RammantBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRoos ColmanGeert VilleirsPiet Ost

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Elke RammantKarel DecaesteckerRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheValerie Fonteyne

A1 Journal Article in CLINICAL REHABILITATION

Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study

Renée BultijnckSofie EveraertElke RammantSteven RimbautValerie FonteyneNicolaas LumenKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy) : protocol for a nonrandomized phase II trial

Valerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A2 Journal Article in JMIR RESEARCH PROTOCOLS

Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer

Renée BultijnckInge Van de CaveyeElke RammantSofie EveraertNicolaas LumenKarel DecaesteckerValerie FonteyneBenedicte DeforchePiet Ost

A1 Journal Article in BJU INTERNATIONAL

Curative treatment for muscle invasive bladder cancer in elderly patients : a systematic review

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie FonteyneElke RammantPiet OstYolande LievensSylvie RotteyDaan De MaeseneerKarel Decaestecker

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Evaluation and preliminary radiation dosimetry of [18F]PSMA-11 for PET imaging of prostate cancer

Sarah PironNick Van LaekenYves D'AsselerKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas LumenBoudewijn BransFilip De Vos

Four- or 5-weeks of radiotherapy for prostate cancer : interim results of a randomized phase 3 trial

Valerie FonteyneElke RammantGert De MeerleerBarbara VanderstraetenNicolaas LumenKarel DecaesteckerPiet Ost

Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah BuelensFilip PoelaertBert DhondtValerie FonteynePieter De VisscherePiet OstSofie VerbekeGeert VilleirsSylvie RotteyKarel DecaesteckerNicolaas Lumen

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes with salvage radiotherapy for rising prostate-specific antigen after surgery : a long-term, multi-institutional analysis

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer

Elke RammantPiet OstRenée BultijnckNicolaas LumenKarel DecaesteckerValerie Fonteyne

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenBieke LambertGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Selecting candidates for early discharge after radical cystectomy for bladder cancer

Valerie FonteyneElke RammantKarel Decaestecker

Editorial material

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenAurélie De BruyckerBieke LambertRenée BultijnckTom ClaeysEls GoetghebeurGeert VilleirsFilip AmeyeGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

The current place of radiotherapy as treatment option for muscle-invasive bladder cancer

Elke RammantKarel DecaesteckerYolande LievensValerie Fonteyne

Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series

Valerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De VisschereDries ReyndersMireille Van GeleLieve BrochezPiet Ost

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie FonteyneElke RammantPiet OstGert De MeerleerKarel Decaestecker

A1 Journal Article in BMC CANCER

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De WolfSylvie RotteyKarim VermaelenKarel DecaesteckerNora SundahlLizzy De LobelEls GoetghebeurGert De MeerleerNicolaas LumenValerie FonteyneDaan De MaeseneerPiet Ost

A1 Journal Article in RADIATION ONCOLOGY

Cytoreductive prostatectomy for metastatic prostate cancer : first lessons learned from the multicentric prospective Local Treatment of Metastatic Prostate Cancer (LoMP) trial

Filip PoelaertKarel DecaesteckerValerie FonteyneSarah BuelensNicolaas Lumen

A1 Journal Article in UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial

Sarah BuelensKarel DecaesteckerValerie FonteynePiet OstSofie VerbekeGeert VilleirsSylvie RotteyNicolaas Lumen

Multicentric prospective Local treatment of Metastatic Prostate cancer (LoMP) trial : evaluation of local events

Sarah BuelensFilip PoelaertBert DhondtBernard RappeValerie FonteyneKarel DecaesteckerNicolaas Lumen

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and therapeutic effect

Filip PoelaertValerie FonteyneKarel DecaesteckerPiet OstSarah BuelensNicolaas Lumen

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy

Aurélie De BruyckerBieke LambertChamberlain MbahGert De MeerleerGeert VilleirsFilip De VosKarel DecaesteckerValerie FonteyneNicolaas LumenPiet Ost

A1 Journal Article in BJU INTERNATIONAL

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter HuyssePiet OstLennart JansAurélie De BruyckerFilip De VosKarel DecaesteckerValerie FonteyneBieke Lambert

A1 Journal Article in DIAGNOSTICS

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol

Elke RammantRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheKarel DecaesteckerValerie Fonteyne

A2 Journal Article in BMJ OPEN

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Tom ClaeysNicolaas LumenCandy KumpsMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsValerie FonteyneKarel Decaestecker

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Whole pelvis radiotherapy for pathological node-positive prostate cancer

Filip PoelaertValerie FonteynePiet OstKarel DecaesteckerGert De MeerleerPieter De VisschereBert DhondtNicolaas Lumen

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE